Safety and efficacy of lixisenatide vs sulfonylurea added to basal insulin in patients with type 2 diabetes who fast during Ramadan (LixiRam): a randomised controlled trial

被引：0
|
作者：
Hassanein, M. M. [1 ]
Hafidh, K. [2 ]
Shehadeh, N. [3 ]
Azar, S. [4 ]
Hanif, W. [5 ]
Li, H. [6 ]
Djaballah, K. [7 ]
Sahay, R. [8 ]
机构：
[1] Dubai Hosp, Dubai, U Arab Emirates
[2] Rashid Hosp, Dubai, U Arab Emirates
[3] Rambam Med Ctr, Haifa, Israel
[4] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[5] Univ Hosp Birmingham, Birmingham, W Midlands, England
[6] Sanofi Aventis China, Beijing, Peoples R China
[7] Sanoti, Paris, France
[8] Osmania Med Coll & Hosp, Hyderabad, Telangana, India
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
757
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [41] Meta-analysis of randomised controlled trials of lixisenatide as add-on to basal insulin and/or oral antidiabetic drugs in patients with type 2 diabetes mellitus
    Puig Domingo, M. L.
    Fonseca, V.
    Wang, E.
    Lin, J.
    Davies, M.
    Tinahones, F. J.
    Charbonnel, B.
    DIABETOLOGIA, 2013, 56 : S362 - S362
  • [42] Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial
    Miya, Aika
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Cho, Kyu Yong
    Nagai, So
    Kurihara, Yoshio
    Aoki, Shin
    Taguri, Masataka
    Terauchi, Yasuo
    Atsumi, Tatsuya
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (01) : 119 - 126
  • [43] Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
    Aroda, Vanita R.
    Rosenstock, Julio
    Wysham, Carol
    Unger, Jeffrey
    Bellido, Diego
    Gonzalez-Galvez, Guillermo
    Takami, Akane
    Guo, Hailing
    Niemoeller, Elisabeth
    Souhami, Elisabeth
    Bergenstal, Richard M.
    DIABETES CARE, 2016, 39 (11) : 1972 - 1980
  • [44] Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
    Sylvie Erpeldinger
    Michaela B. Rehman
    Christophe Berkhout
    Christophe Pigache
    Yves Zerbib
    Francis Regnault
    Emilie Guérin
    Irène Supper
    Catherine Cornu
    Behrouz Kassaï
    François Gueyffier
    Rémy Boussageon
    BMC Endocrine Disorders, 16
  • [45] Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
    Erpeldinger, Sylvie
    Rehman, Michaela B.
    Berkhout, Christophe
    Pigache, Christophe
    Zerbib, Yves
    Regnault, Francis
    Guerin, Emilie
    Supper, Irene
    Cornu, Catherine
    Kassai, Behrouz
    Gueyffier, Francois
    Boussageon, Remy
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [46] From guidelines to clinical practice, reflections on the multinational randomised trial investigating the efficacy and safety of insulin degludec/insulin aspart and biphasic aspart 30 in patients with Type 2 diabetes before, during and after Ramadan
    Hassanein, M.
    Fita, E. G.
    Ekelund, M.
    DIABETIC MEDICINE, 2018, 35 : 203 - 203
  • [47] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
    Wilding, J. P. H.
    Charpentier, G.
    Hollander, P.
    Gonzalez-Galvez, G.
    Mathieu, C.
    Vercruysse, F.
    Usiskin, K.
    Law, G.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
  • [48] Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on sulfonylurea ± metformin (GetGoal-S)
    Ratner, R. E.
    Hanefeld, M.
    Shamanna, P.
    Min, K.
    Boka, G.
    Miossec, P.
    Muehlen-Bartmer, I.
    Rosenstock, J.
    DIABETOLOGIA, 2011, 54 : S317 - S317
  • [49] Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus
    Ibrahim, Mahmoud
    Barker, Mary Moffett
    Ahmad, Ehtasham
    Ahmed, Asma
    Annabi, Firas A.
    Ba-Essa, Ebtesam M.
    Davies, Melanie J.
    Houeiss, Pamela
    Iraqi, Hinde
    Masood, Shabeen Naz
    Mimouni-Zerguini, Safia
    Shaikh, Shehla
    Tantawi, Hyam
    Tuomilehto, Jaakko
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (03)
  • [50] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes The SURPASS-6 Randomized Clinical Trial
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1631 - 1640
12345